Apart from the known regulators CD44 (56) and CXCR4 (57), we also newly identified PTPN6, which is associated with tumor rejection (61, 63) and T-cell aggregation (62, 63), to be essential in promoting renal transplantation rejection. Here, PTPN6 is linked to neoplasm.